Drug Shortage Report for BIO-EZETIMIBE

Last updated on 2017-05-12 History
Report ID 7702
Drug Identification Number 02425211
Brand name BIO-EZETIMIBE
Common or Proper name EZETIMIBE
Company Name BIOMED PHARMA
Market Status MARKETED
Active Ingredient(s) EZETIMIBE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-04-24
Actual start date 2017-04-24
Estimated end date 2017-05-02
Actual end date 2017-05-11
Shortage status Resolved
Updated date 2017-05-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-04-24 English Compare
v2 2017-04-24 English Compare
v3 2017-04-24 French Compare
v4 2017-04-25 English Compare
v5 2017-05-11 English Compare
v6 2017-05-11 French Compare
v7 2017-05-11 French Compare
v8 2017-05-12 English Compare

Showing 1 to 8 of 8